Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15007 total
WAY enters the final week of August with an uncomfortable tension at its core: the founder-CEO has been selling shares steadily into a stock that is up 7.5% over the past month, while the Street's bull consensus…
AngloGold Ashanti has rarely moved this fast — a 26% weekly gain and 55% advance over the past month that has left shorts scrambling and options traders stacking puts at the most defensive reading in months. The most…
IBIT enters the back half of August with a striking divergence: the ETF has rallied 22% in a single week while the options market has snapped back to its most call-friendly reading in months — a sharp reversal from the…
Bitdeer Technologies Group is posting its strongest weekly gain in months — up 25% — yet the bears have barely blinked, leaving the stock in an unusual tug-of-war between a sharp price recovery and one of the most…
Super Hi International Holding Ltd. heads into the week with its lending market loosening at pace — short sellers are covering, cost to borrow has halved over the past month, and availability is opening up, even as the…
QGRW closed at $66.90 on August 25, up 0.6% on the day and 5.5% higher over the past month, as the WisdomTree U.S. Quality Growth Fund rides a broader recovery in growth-oriented equities. The headline tension this…
Biohaven Ltd. enters the final week of August with an unusual configuration: short interest at a genuinely elevated 13.4% of free float, yet falling fast, while the options market tilts aggressively bullish and the…
RUM Group has just posted a 26% weekly gain and 79% monthly surge — yet the lending market tells a story that makes the rally look fragile and the short position look increasingly trapped. The borrow picture is the…
D-Wave Quantum enters the final week of August with a curious split: short sellers added positions at the fastest weekly pace in months, yet the borrow market has simultaneously become the most accessible it has been…
SoundHound AI heads into late August with its short position marginally smaller than last week — but the structural stalemate in the lending market is now in its fifth consecutive week with no sign of resolution. Short…
Excelerate Energy is presenting a rare tension this week: the stock is up 6.4% on the week to $39.65, yet options traders have swung to their most defensive posture in a year, while short sellers quietly add exposure…
TPG enters the back half of August with a striking divergence: short sellers are abandoning positions at pace, the stock has rallied 23% over the past month, and options traders just made one of the most decisive…
nCino reported earnings on August 26, and the Street has moved quickly to push targets higher — a broad analyst upgrade wave running alongside continued short covering that gives the post-print setup a notably…
IREN arrives at its August 27 print with bears making a small retreat — but the short base remains one of the most entrenched in digital infrastructure, and the borrow market is still effectively sealed. The most…
Nuvectis Pharma has extended its August rally to nearly 24% on the week and 34% on the month — and options traders are now the most aggressively bullish they have been all year. The options signal is the sharpest edge…
GTLB arrives at its August 31 earnings report with a dramatically different short-interest picture than it carried just one week ago — bears have been cutting positions at the fastest pace in months, even as analysts…
Rocket Lab Corporation enters the final stretch of August with a sharp week-behind it and options traders the most defensively positioned they have been all year. The stock fell 15.5% over the past five sessions to…
Caris Life Sciences is the biotech story of the week, with shares up 34% in five sessions and 80% over the past month — yet the short-selling and options data tell a story of measured repositioning rather than a forced…
GeneDx Holdings has put up one of the more striking moves in the genomics space this month — up nearly 48% in 30 days and 14.5% in the past week alone to close at $87.41 — yet the short side of the ledger tells a story…
The tension that defined OPFI earlier this week has sharpened further — the CEO is still buying every day, shorts keep adding, and now options traders have broken decisively from the cautious posture they held all…
